Publishing the world's first monograph about Clostridium Butyricum

The research specialist staff of Qingdao Eastsea Pharmaceutical Co. Ltd. has published the world's first monograph about Clostridium Butyricum Clostridium Butyricum----The Kavass of Intestinal Tract.   The book expounded on the importance of Clostridium butyricum to the intestinal from the perspective of microflora. It introduced the use of Clostridium butyricum at the field of healing chronic diarrhea, constipation, IBS and IBD, and the precaution affect to intestinal cancer. It also introduced the effect of intestinal mucosal regeneration, repairing and immunization balance. It did a test on the pathogenesis of IBS and IBD at the molecular, cellular, tissue and organ, and made a neodoxy “Clostridium butyricum is more conducive to human health than Lactobacillus ", it also introduced the relevant Clostridium butyricum products and patents.